Modulating immune system development and function through microrna mir-146
AssigneeCalifornia Institute of Technology
InventorsDavid Baltimore, Mark Boldin, Konstantin Taganov
Life of this patent
Estimating the term…
Loading patent…
AssigneeCalifornia Institute of Technology
InventorsDavid Baltimore, Mark Boldin, Konstantin Taganov
Estimating the term…
The present disclosure relates to the finding that microRNA-146 plays a role in modulating the development and function of the immune system. Immune cell development and function can be modulated by delivery of microRNA-146 (miR-146) or antisense miR-146 to target immune cells or precursor cells. For example, in some embodiments, activity and/or proliferation of certain immune cells is regulated by administering miR-146 oligonucleotides or anti-miR-146 oligonucleotides. In other embodiments, pro-inflammatory cytokine expression in immune cells is regulated by administering a miR-146 oligonucleotide or anti-miR-146. In further embodiments, methods of regulating macrophage activity using antisense miR-146 are provided. Additional methods and compositions for regulating immune system function and development using miR-146 are disclosed.
A transgenic mouse, wherein the genome of the transgenic mouse comprises a homozygous disruption of the endogenous miRNA-146 gene.
A transgenic mouse, wherein the transgenic mouse comprises a homozygous disruption of 295 base pairs of an endogenous sequence encoding pre-miR-146a.
A cell from a transgenic mouse, wherein the transgenic mouse comprises a homozygous deletion of 295 base pairs of an endogenous sequence encoding pre-miR-146a.
Dependencies are inferred from the claim text.